1. Home
  2. CRSP vs GT Comparison

CRSP vs GT Comparison

Compare CRSP & GT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • GT
  • Stock Information
  • Founded
  • CRSP 2013
  • GT 1898
  • Country
  • CRSP Switzerland
  • GT United States
  • Employees
  • CRSP 393
  • GT N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • GT Automotive Aftermarket
  • Sector
  • CRSP Health Care
  • GT Consumer Discretionary
  • Exchange
  • CRSP Nasdaq
  • GT Nasdaq
  • Market Cap
  • CRSP 3.3B
  • GT 3.1B
  • IPO Year
  • CRSP 2016
  • GT N/A
  • Fundamental
  • Price
  • CRSP $35.62
  • GT $10.86
  • Analyst Decision
  • CRSP Buy
  • GT Strong Buy
  • Analyst Count
  • CRSP 17
  • GT 3
  • Target Price
  • CRSP $74.53
  • GT $14.30
  • AVG Volume (30 Days)
  • CRSP 2.0M
  • GT 5.4M
  • Earning Date
  • CRSP 05-06-2025
  • GT 05-07-2025
  • Dividend Yield
  • CRSP N/A
  • GT N/A
  • EPS Growth
  • CRSP N/A
  • GT N/A
  • EPS
  • CRSP N/A
  • GT 0.84
  • Revenue
  • CRSP $37,675,000.00
  • GT $18,594,000,000.00
  • Revenue This Year
  • CRSP $51.35
  • GT $0.54
  • Revenue Next Year
  • CRSP $282.16
  • GT $2.44
  • P/E Ratio
  • CRSP N/A
  • GT $12.96
  • Revenue Growth
  • CRSP N/A
  • GT N/A
  • 52 Week Low
  • CRSP $30.04
  • GT $7.27
  • 52 Week High
  • CRSP $67.88
  • GT $13.26
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 44.74
  • GT 58.62
  • Support Level
  • CRSP $33.03
  • GT $10.61
  • Resistance Level
  • CRSP $39.38
  • GT $11.44
  • Average True Range (ATR)
  • CRSP 1.81
  • GT 0.37
  • MACD
  • CRSP -0.19
  • GT -0.01
  • Stochastic Oscillator
  • CRSP 33.64
  • GT 58.57

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About GT The Goodyear Tire & Rubber Company

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.

Share on Social Networks: